| mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
| mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |
| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.0098 |
0.9 |
| mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.0094 |
0.9 |